Ultra-short acting beta-blockers: A proposal for the treatment of the critically ill patient-Reference-Cited by-同舟云学术

Ultra-short acting beta-blockers: A proposal for the treatment of the critically ill patient

Published:1982-08 Issue:9 Volume:31 Page:899-907
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Zaroslinski John,Borgman Robert J.,O'Donnell John P.,Anderson William G.,Erhardt Paul W.,Kam Sheung-Tsam,Reynolds Robert D.,Lee Robert J.,Gorczynski Richard J.

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference24 articles.

1. Adrenoceptor Blocking Drugs

2. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applications

3. Present state of alpha and beta adrenergic drugs III. Beta blocking agents

4. Proceedings of the VIII World Congress of Cardiology;Szekeres,1978

5. Beta-adrenergic blockade in acute myocardial infarction

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Esmolol (soft drug design);Overcoming Obstacles in Drug Discovery and Development;2023

2. Pharmacological Chaperones;Protein Homeostasis in Drug Discovery;2022-11-14

3. Prodrugs: Strategic Deployment, Metabolic Considerations, and Chemical Design Principles;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26

4. Effects of esmolol infusion on cardiovascular parameters and quality of general anaesthesia in younger and older patients;Scripta Medica;2021

5. SUPPRESSION OF PRESSOR RESPONSE DURING LARYNGOSCOPY AND ENDOTRACHEAL INTUBATION BY ESMOLOL ADMINISTERED IN DOSES OF 1.5 mg/kg, 2.25 mg/kg: A COMPARATIVE CLINICAL STUDY;Journal of Evolution of Medical and Dental Sciences;2016-03-23